Switch from adalimumab to brodalumab as a possible trigger factor for the onset of pyoderma gangrenosum

Australas J Dermatol. 2024 Apr 10. doi: 10.1111/ajd.14266. Online ahead of print.NO ABSTRACTPMID:38597123 | DOI:10.1111/ajd.14266

Source: The Australasian Journal of Dermatology - April 10, 2024 Category: Dermatology Authors: Giorgia Salvia Matteo Bevilacqua Flavia Manzo Margiotta Alessandra Michelucci Giammarco Granieri Cristian Fidanzi Valentina Dini Marco Romanelli Carlo Mazzatenta Source Type: research